Noah Editorial
Blog
Timely research perspectives, biotech market signals, and clinical updates in a cleaner long-form reading format.
February 26, 2026
•Research ProgressWeekly Biotech Watchlist: KDO (Tarcocimab), KZIA (Paxalisib)
Probability-weighted analysis of two clinical catalysts: tarcocimab (Phase 3, DR) and paxalisib (Phase 1b, TNBC), with estimated success rates and key risks.
By linda
February 26, 2026
•Use CasesNoah AI Tutorial: Mastering Your AI-Powered Biopharma & Medical Research Assistant
A guide to Noah AI's three core modules—Agent & Search, Database, and News—helping biopharma researchers search smarter and analyze faster.
By linda
February 26, 2026
•How-toHow to search for the latest authoritative medical data?
Noah's Health Search retrieves the latest medical data from trusted sources like CDC, NIH, and Mayo Clinic, with in-depth AI analysis.
By maxin
February 26, 2026
•Use CasesWhere can I get the latest medical news?
Noah's AI-powered News platform curates global biopharma news, reconstructs full stories from multiple sources, and enables deep-dive Q&A on any event.
By maxin
January 28, 2026
•Research ProgressNVIDIA × Eli Lilly AI Co-Innovation Lab: A $1B Blueprint for AI-Driven Drug Discovery
NVIDIA and Eli Lilly's $1B AI co-innovation lab aims to transform drug discovery into a systematic engineering workflow—a blueprint for AI in life sciences.
By linda
January 28, 2026
•Research ProgressWhat’s Driving the ADHD Market? A Global View of Treatments and the Pipeline
A global view of the ADHD treatment landscape: marketed therapies, clinical pipeline highlights, and a scenario-based market growth outlook for 2026–2030.
By linda